Fatal heart failure associated with CoQ10 and multiple OXPHOS deficiency in a child with propionic acidemia

Mitochondrion

Volumn 11, Issue 3, 2011, Pages 533-536

  Fragaki, Konstantina ^a,b   Cano, Aline ^c   Benoist, Jean François ^d   Rigal, Odile ^d   Chaussenot, Annabelle ^a   Rouzier, Cécile ^a,b   Bannwarth, Sylvie ^a,b   Caruba, Céline ^e   Chabrol, Brigitte ^c   Paquis Flucklinger, Veronique ^a,b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e PASTEUR HOSPITAL   (France)

Author keywords

CoQ10 deficiency; Mitochondrial disorders; Propionic acidemia

Indexed keywords

CITRATE SYNTHASE; CITRIC ACID; GLYCINE; METRONIDAZOLE; PROPIONIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE;

ACUTE HEART FAILURE; ARTICLE; ASTHENIA; BRAIN ATROPHY; CARDIOGENIC SHOCK; CASE REPORT; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME DEFICIENCY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS FRAGMENTOGRAPHY; MUSCLE WEAKNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; PROTEIN RESTRICTION; PTOSIS; VOMITING;

CHILD; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX III; HEART FAILURE; HUMANS; LIVER; MALE; MITOCHONDRIAL DISEASES; PROPIONIC ACIDEMIA; UBIQUINONE;

EID: 79953758676     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2011.02.002     Document Type: Article

References (26)

1. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annal. Biochem. 1976, 72:248-254.
2. Brock M., Buckel W. On the mechanism of action of the antifungal agent propionate. Eur. J. Biochem. 2004, 271:3727-3741.
3. Burlina A., Dionisi-Vici C., Piovan S., Saponara I., Bartuli A., Sabetta G., Zachello F. Acute pancreatitis in propionic acidemia. J. Inherit. Metab. Dis. 1995, 18:169-172.
4. Cheema-Dhadii S., Leznoff C., Halperin M. Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr. Res. 1975, 9:905-908.
5. de Keyzer Y., Valayannopoulos V., Benoist J., Batteux F., Lacaille F., Hubert L., Chretien D., Chadefeaux-Vekemans B., Niaudet P., Touati G., et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr. Res. 2009, 66:91-95.
6. Deodato F., Boenzi S., Santorelli F., Dionisi-Vici C. Methylmalonic and propionic aciduria. Am. J. Med. Genet. 2006, 142C:104-122.
7. Gregersen N. The specific inhibition of thepyruvate dehydrogenase complex from pig kidney in propionyl-CoA and isovaleryl-CoA. Biochem. Med. 1981, 26:20-27.
8. Horswill A., Dudding A., Escalante-Semerena J. Studies of propionate toxicity in Salmonella Enterica identify 2-methylcitrate as a potent inhibitor of cell growth. J. Biol. Chem. 2001, 276:19094-19101.
9. Kahler S., Sherwood W., Woolf D., Lawless S., Zaritsky A., Bonham J., Taylor C., Clarke J., Durie P., Leonard J. Pancreatitis in patients with organic acidemias. J. Pediatr. 1994, 124:239-243.
10. 10 deficiency. Neurochem. Res. 2007, 32:837-843.
11. Lerman-Sagie T., Rustin P., Lev D., Yanoov M., Leshinsky-Silver E., Sagie A., Ben-Gal T., Munnich A. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J. Inherit. Metab. Dis. 2001, 24:443-450.
12. Leshinsky-Silver E., Levine A., Nissenkorn A., Barash V., Perach M., Buzhaker E., Shahmurov M., Polak-Charcon S., Lev D., Lerman-Sagie T. Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS deficiency. Mol. Genet. Metab. 2003, 79:288-293.
13. Mardach R., Anthony Verity M., Cederbaum S. Clinical, pathological, and biochemical studies in a patient with propionic acidemia and fatal cardiomyopathy. Mol. Genet. Metab. 2005, 85:286-290.
14. Massoud A., Leonard J. Cardiomyopathy in propionic acidaemia. Eur. J. Pediatr. 1993, 152:441-445.
15. Mc Guire P., Parikh A., Diaz G. Profiling of oxidative stress in patients with inborn errors of metabolism. Mol. Genet. Metab. 2009, 98:173-180.
16. 10 deficiency syndromes. Clin. Biochem. 2008, 41:697-700.
17. Ogier de Baulny H., Benoist J., Rigal O., Touati G., Rabier D., Saudubray J. Methyl malonic and propionic acidemias: management and outcome. J. Inherit. Metab. Dis. 2005, 28:415-423.
18. Perez-Cerda C., Merinero B., Marti M., Cabrera J., Pena L., Garcia M., Gangoiti J., Sanz P., Rodriguez-Pombo P., Hoenicka J., et al. An unusual late-onset case of propionic acidaemia: biochemical investigations, neuroradiological findings and mutation analysis. Eur. J. Pediatr. 1998, 157:50-52.
19. Pettenuzzo L., Schuck P., Fontella F., Wannmacher C., Wyse A., Dutra-Filho C., Netto C., Wajner M. Ascorbic acid prevents cognitive deficits caused by chronic administration of propionic acid to rats in the water maze. Pharmacol. Biochem. Behav. 2002, 73:623-629.
20. Rigo F., Pasquetti L., Malfatti C., Fighera M., Coelho R., Petri Z., Mello C. Propionic acid induces convulsions and protein carbonylation in rats. Neurosci. Lett. 2006, 408:151-154.
21. Rotig A., Mollet J., Rio M., Munnich A. Infantile and pediatric quinone deficiency diseases. Mitochondrion 2007, 7:S212-S221.
22. Rouzier C., Le Guédard-Méreuze S., Fragaki K., Serre V., Miro J., Tuffery-Giraud S., Chaussenot A., Bannwarth S., Caruba S., Ostergaard E., et al. The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein. J. Med. Genet. 2010, 47(10):670-676.
23. Rustin P., Chretien D., Bourgeron T., Gerard B., Rotig A., Saudubray J. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chem. Acta 1994, 228:31-51.
24. Schwab M., Sauer S., Okun J., Nijtmans L., Rodenburg R., van den Heuvel L., Drose S., Brandt U., Hoffman G., Ter Laak H., et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem. J. 2006, 398:107-112.
25. Surtees R., Matthews E., Leonard J. Neurologic outcome of propionic acidemia. Pediatr. Neurol. 1992, 8:333-337.
26. Touati G., Valayannopoulos V., Mention K., de Lonlay P., Jouvet P., Depondt E., Assoun M., Souberbielle J., Rabier D., Ogier de Baulny H., et al. Methylmalonic and propionic acidurias: management without or a few supplements of specific amino acid mixture. J. Inherit. Metab. Dis. 2006, 29:288-298.